Aspira Women's Health Inc. (AWH)
USD 0.08
(0.0%)
USD 0.08
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.43 Million USD | -44.72% |
| 2022 | 2.58 Million USD | -15.65% |
| 2021 | 3.06 Million USD | -12.02% |
| 2020 | 3.48 Million USD | 217.2% |
| 2019 | 1.09 Million USD | -14.94% |
| 2018 | 1.29 Million USD | -12.76% |
| 2017 | 1.48 Million USD | -11.16% |
| 2016 | 1.66 Million USD | 2546.03% |
| 2015 | 63 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 5 Million USD | -50.0% |
| 2009 | 10 Million USD | -38.94% |
| 2008 | 16.37 Million USD | -37.48% |
| 2007 | 26.19 Million USD | 2.69% |
| 2006 | 25.51 Million USD | -19.69% |
| 2005 | 31.76 Million USD | 11.62% |
| 2004 | 28.45 Million USD | -7.85% |
| 2003 | 30.87 Million USD | 1235.02% |
| 2002 | 2.31 Million USD | 11.04% |
| 2001 | 2.08 Million USD | 391.27% |
| 2000 | 424 Thousand USD | -12.22% |
| 1999 | 483 Thousand USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.34 Million USD | -5.8% |
| 2024 Q2 | 1.26 Million USD | -6.16% |
| 2023 Q1 | 2.45 Million USD | -5.14% |
| 2023 Q2 | 1.56 Million USD | -36.35% |
| 2023 Q3 | 1.64 Million USD | 5.38% |
| 2023 Q4 | 1.43 Million USD | -13.12% |
| 2023 FY | 1.43 Million USD | -44.72% |
| 2022 Q4 | 2.58 Million USD | -4.85% |
| 2022 FY | 2.58 Million USD | -15.65% |
| 2022 Q2 | 2.85 Million USD | -4.3% |
| 2022 Q1 | 2.97 Million USD | -2.9% |
| 2022 Q3 | 2.71 Million USD | -4.6% |
| 2021 Q3 | 3.13 Million USD | -2.06% |
| 2021 Q4 | 3.06 Million USD | -2.14% |
| 2021 FY | 3.06 Million USD | -12.02% |
| 2021 Q1 | 3.82 Million USD | 9.7% |
| 2021 Q2 | 3.2 Million USD | -16.32% |
| 2020 FY | 3.48 Million USD | 217.2% |
| 2020 Q1 | 1.05 Million USD | -4.46% |
| 2020 Q2 | 1.61 Million USD | 53.81% |
| 2020 Q3 | 2.1 Million USD | 30.03% |
| 2020 Q4 | 3.48 Million USD | 66.0% |
| 2019 FY | 1.09 Million USD | -14.94% |
| 2019 Q2 | 1.19 Million USD | -3.86% |
| 2019 Q1 | 1.24 Million USD | -3.72% |
| 2019 Q3 | 1.14 Million USD | -4.01% |
| 2019 Q4 | 1.09 Million USD | -4.27% |
| 2018 Q4 | 1.29 Million USD | -3.58% |
| 2018 Q1 | 1.43 Million USD | -3.17% |
| 2018 Q2 | 1.38 Million USD | -3.28% |
| 2018 FY | 1.29 Million USD | -12.76% |
| 2018 Q3 | 1.34 Million USD | -3.39% |
| 2017 Q3 | 1.52 Million USD | -0.65% |
| 2017 Q2 | 1.53 Million USD | -3.45% |
| 2017 FY | 1.48 Million USD | -11.16% |
| 2017 Q4 | 1.48 Million USD | -3.08% |
| 2017 Q1 | 1.59 Million USD | -4.44% |
| 2016 FY | 1.66 Million USD | 2546.03% |
| 2016 Q1 | 55 Thousand USD | -12.7% |
| 2016 Q2 | 1.75 Million USD | 3096.36% |
| 2016 Q3 | 1.7 Million USD | -3.07% |
| 2016 Q4 | 1.66 Million USD | -2.17% |
| 2015 Q4 | 63 Thousand USD | -11.27% |
| 2015 FY | 63 Thousand USD | 0.0% |
| 2015 Q3 | 71 Thousand USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q1 | 7 Million USD | 40.0% |
| 2011 Q3 | 7 Million USD | 0.0% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q2 | 7 Million USD | 0.0% |
| 2010 Q2 | 12 Million USD | 0.0% |
| 2010 FY | 5 Million USD | -50.0% |
| 2010 Q1 | 12 Million USD | 20.0% |
| 2010 Q4 | 5 Million USD | -28.57% |
| 2010 Q3 | 7 Million USD | -41.67% |
| 2009 Q4 | 10 Million USD | 0.0% |
| 2009 Q1 | 10 Million USD | -38.94% |
| 2009 FY | 10 Million USD | -38.94% |
| 2009 Q3 | 10 Million USD | 0.0% |
| 2009 Q2 | 10 Million USD | 0.0% |
| 2008 Q3 | 26.33 Million USD | 0.17% |
| 2008 FY | 16.37 Million USD | -37.48% |
| 2008 Q1 | 26.24 Million USD | 0.18% |
| 2008 Q2 | 26.28 Million USD | 0.17% |
| 2008 Q4 | 16.37 Million USD | -37.8% |
| 2007 FY | 26.19 Million USD | 2.69% |
| 2007 Q1 | 27.21 Million USD | 6.68% |
| 2007 Q2 | 28.55 Million USD | 4.91% |
| 2007 Q3 | 26.15 Million USD | -8.42% |
| 2007 Q4 | 26.19 Million USD | 0.18% |
| 2006 Q3 | 35.23 Million USD | 4.05% |
| 2006 FY | 25.51 Million USD | -19.69% |
| 2006 Q1 | 32.49 Million USD | 2.29% |
| 2006 Q2 | 33.86 Million USD | 4.24% |
| 2006 Q4 | 25.51 Million USD | -27.61% |
| 2005 Q2 | 28.36 Million USD | -0.11% |
| 2005 Q1 | 28.39 Million USD | -0.21% |
| 2005 Q3 | 29.74 Million USD | 4.86% |
| 2005 Q4 | 31.76 Million USD | 6.78% |
| 2005 FY | 31.76 Million USD | 11.62% |
| 2004 Q2 | 31.07 Million USD | 1.2% |
| 2004 FY | 28.45 Million USD | -7.85% |
| 2004 Q4 | 28.45 Million USD | -8.16% |
| 2004 Q1 | 30.7 Million USD | -0.56% |
| 2004 Q3 | 30.98 Million USD | -0.3% |
| 2003 Q2 | 3.69 Million USD | 71.68% |
| 2003 Q3 | 30.81 Million USD | 733.29% |
| 2003 Q4 | 30.87 Million USD | 0.21% |
| 2003 Q1 | 2.15 Million USD | -6.87% |
| 2003 FY | 30.87 Million USD | 1235.02% |
| 2002 Q3 | 2.24 Million USD | 5.41% |
| 2002 Q1 | 1.92 Million USD | -7.63% |
| 2002 FY | 2.31 Million USD | 11.04% |
| 2002 Q4 | 2.31 Million USD | 3.26% |
| 2002 Q2 | 2.12 Million USD | 10.45% |
| 2001 Q4 | 2.08 Million USD | -6.97% |
| 2001 Q3 | 2.23 Million USD | 908.56% |
| 2001 Q2 | 222 Thousand USD | -33.13% |
| 2001 FY | 2.08 Million USD | 391.27% |
| 2001 Q1 | 332 Thousand USD | -21.7% |
| 2000 Q4 | 424 Thousand USD | -17.51% |
| 2000 Q3 | 514 Thousand USD | 0.0% |
| 2000 FY | 424 Thousand USD | -12.22% |
| 1999 FY | 483 Thousand USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3.07 Million USD | 53.481% |
| Biodesix, Inc. | 35.22 Million USD | 95.94% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -27.853% |
| Castle Biosciences, Inc. | 14.19 Million USD | 89.928% |
| DarioHealth Corp. | 24.59 Million USD | 94.185% |
| Exact Sciences Corporation | 2.47 Billion USD | 99.942% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 99.77% |
| Illumina, Inc. | 1.48 Billion USD | 99.904% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -1658.399% |
| iSpecimen Inc. | 29.13 Thousand USD | -4809.028% |
| Standard BioTools Inc. | 3.98 Million USD | 64.097% |
| 23andMe Holding Co. | 67.84 Million USD | 97.892% |
| Medpace Holdings, Inc. | 142.12 Million USD | 98.994% |
| NeoGenomics, Inc. | 606.06 Million USD | 99.764% |
| Inotiv, Inc. | 399.4 Million USD | 99.642% |
| Psychemedics Corporation | 945 Thousand USD | -51.323% |
| Prenetics Global Limited | 867.21 Thousand USD | -64.896% |
| Precipio, Inc. | 106 Thousand USD | -1249.057% |
| RadNet, Inc. | 812.06 Million USD | 99.824% |
| Sotera Health Company | 2.22 Billion USD | 99.936% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -24.891% |
| Exagen Inc. | 19.23 Million USD | 92.564% |
| Natera, Inc. | 282.94 Million USD | 99.495% |
| Neogen Corporation | 888.39 Million USD | 99.839% |
| Myriad Genetics, Inc. | 130.9 Million USD | 98.908% |
| ICON Public Limited Company | 3.66 Billion USD | 99.961% |
| Bionano Genomics, Inc. | 7.17 Million USD | 80.07% |
| CareDx, Inc | 28.27 Million USD | 94.943% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 79.17 Million USD | 98.194% |
| Guardant Health, Inc. | 1.13 Billion USD | 99.875% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -1347.911% |
| Fulgent Genetics, Inc. | 10.11 Million USD | 85.857% |
| Sera Prognostics, Inc. | 840 Thousand USD | -70.238% |
| OPKO Health, Inc. | 222.03 Million USD | 99.356% |
| Personalis, Inc. | 1.23 Million USD | -15.883% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -93.462% |
| Star Equity Holdings, Inc. | 1.14 Million USD | -24.891% |
| MDxHealth SA | 35.56 Million USD | 95.979% |
| Prenetics Global Limited | 867.21 Thousand USD | -64.896% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -644.551% |
| Mainz Biomed B.V. | 2.19 Million USD | 34.878% |
| Trinity Biotech plc | 54.65 Million USD | 97.383% |
| Neuronetics, Inc. | 59.28 Million USD | 97.588% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | -27.853% |